Cargando…

Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus

BACKGROUND AND PURPOSE: Protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the cerebrospinal fluid (CSF) of patients with probable idiopathic normal‐pressure hydrocephalus (iNPH) by proteome analysis. We aimed to assess the feasibility of using CSF PTPRQ concentrations for the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, M., Rauramaa, T., Mäkinen, P. M., Hiltunen, M., Herukka, S.‐K., Kokki, M., Musialowicz, T., Jyrkkänen, H.‐K., Danner, N., Junkkari, A., Koivisto, A. M., Jääskeläinen, J. E., Miyajima, M., Ogino, I., Furuta, A., Akiba, C., Kawamura, K., Kamohara, C., Sugano, H., Tange, Y., Karagiozov, K., Leinonen, V., Arai, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821334/
https://www.ncbi.nlm.nih.gov/pubmed/33035386
http://dx.doi.org/10.1111/ene.14575
_version_ 1783639401675358208
author Nakajima, M.
Rauramaa, T.
Mäkinen, P. M.
Hiltunen, M.
Herukka, S.‐K.
Kokki, M.
Musialowicz, T.
Jyrkkänen, H.‐K.
Danner, N.
Junkkari, A.
Koivisto, A. M.
Jääskeläinen, J. E.
Miyajima, M.
Ogino, I.
Furuta, A.
Akiba, C.
Kawamura, K.
Kamohara, C.
Sugano, H.
Tange, Y.
Karagiozov, K.
Leinonen, V.
Arai, H.
author_facet Nakajima, M.
Rauramaa, T.
Mäkinen, P. M.
Hiltunen, M.
Herukka, S.‐K.
Kokki, M.
Musialowicz, T.
Jyrkkänen, H.‐K.
Danner, N.
Junkkari, A.
Koivisto, A. M.
Jääskeläinen, J. E.
Miyajima, M.
Ogino, I.
Furuta, A.
Akiba, C.
Kawamura, K.
Kamohara, C.
Sugano, H.
Tange, Y.
Karagiozov, K.
Leinonen, V.
Arai, H.
author_sort Nakajima, M.
collection PubMed
description BACKGROUND AND PURPOSE: Protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the cerebrospinal fluid (CSF) of patients with probable idiopathic normal‐pressure hydrocephalus (iNPH) by proteome analysis. We aimed to assess the feasibility of using CSF PTPRQ concentrations for the additional diagnostic criterion of iNPH in Japanese and Finnish populations. METHODS: We compared PTPRQ concentrations among patients with probable iNPH and neurologically healthy individuals (normal control [NC] group), patients with normal‐pressure hydrocephalus (NPH) of acquired and congenital/developmental aetiologies, patients with Alzheimer’s disease and patients with Parkinson’s disease in a Japanese analysis cohort. A corresponding iNPH group and NC group in a Finnish cohort was used for validation. Patients in the Finnish cohort who underwent biopsy were classified into two groups based on amyloid and/or tau deposition. We measured PTPRQ expression levels in autopsied brain specimens of iNPH patients and the NC group. RESULTS: Cerebrospinal fluid PTPRQ concentrations in the patients with NPH of idiopathic, acquired and congenital/developmental aetiologies were significantly higher than those in the NC group and those with Parkinson’s disease, but iNPH showed no significant differences when compared with those in the Alzheimer’s disease group. For the patients with iNPH, the area under the receiver‐operating characteristic curve was 0.860 in the Japanese iNPH and 0.849 in the Finnish iNPH cohorts. Immunostaining and in situ hybridization revealed PTPRQ expression in the ependymal cells and choroid plexus. It is highly possible that the elevated PTPRQ levels in the CSF are related to ependymal dysfunction from ventricular expansion. CONCLUSIONS: Cerebrospinal fluid PTPRQ levels indicated the validity of this assay for auxiliary diagnosis of adult chronic hydrocephalus.
format Online
Article
Text
id pubmed-7821334
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78213342021-01-29 Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus Nakajima, M. Rauramaa, T. Mäkinen, P. M. Hiltunen, M. Herukka, S.‐K. Kokki, M. Musialowicz, T. Jyrkkänen, H.‐K. Danner, N. Junkkari, A. Koivisto, A. M. Jääskeläinen, J. E. Miyajima, M. Ogino, I. Furuta, A. Akiba, C. Kawamura, K. Kamohara, C. Sugano, H. Tange, Y. Karagiozov, K. Leinonen, V. Arai, H. Eur J Neurol Dementia and Cognitive Disorders BACKGROUND AND PURPOSE: Protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the cerebrospinal fluid (CSF) of patients with probable idiopathic normal‐pressure hydrocephalus (iNPH) by proteome analysis. We aimed to assess the feasibility of using CSF PTPRQ concentrations for the additional diagnostic criterion of iNPH in Japanese and Finnish populations. METHODS: We compared PTPRQ concentrations among patients with probable iNPH and neurologically healthy individuals (normal control [NC] group), patients with normal‐pressure hydrocephalus (NPH) of acquired and congenital/developmental aetiologies, patients with Alzheimer’s disease and patients with Parkinson’s disease in a Japanese analysis cohort. A corresponding iNPH group and NC group in a Finnish cohort was used for validation. Patients in the Finnish cohort who underwent biopsy were classified into two groups based on amyloid and/or tau deposition. We measured PTPRQ expression levels in autopsied brain specimens of iNPH patients and the NC group. RESULTS: Cerebrospinal fluid PTPRQ concentrations in the patients with NPH of idiopathic, acquired and congenital/developmental aetiologies were significantly higher than those in the NC group and those with Parkinson’s disease, but iNPH showed no significant differences when compared with those in the Alzheimer’s disease group. For the patients with iNPH, the area under the receiver‐operating characteristic curve was 0.860 in the Japanese iNPH and 0.849 in the Finnish iNPH cohorts. Immunostaining and in situ hybridization revealed PTPRQ expression in the ependymal cells and choroid plexus. It is highly possible that the elevated PTPRQ levels in the CSF are related to ependymal dysfunction from ventricular expansion. CONCLUSIONS: Cerebrospinal fluid PTPRQ levels indicated the validity of this assay for auxiliary diagnosis of adult chronic hydrocephalus. John Wiley and Sons Inc. 2020-11-01 2021-02 /pmc/articles/PMC7821334/ /pubmed/33035386 http://dx.doi.org/10.1111/ene.14575 Text en © 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Dementia and Cognitive Disorders
Nakajima, M.
Rauramaa, T.
Mäkinen, P. M.
Hiltunen, M.
Herukka, S.‐K.
Kokki, M.
Musialowicz, T.
Jyrkkänen, H.‐K.
Danner, N.
Junkkari, A.
Koivisto, A. M.
Jääskeläinen, J. E.
Miyajima, M.
Ogino, I.
Furuta, A.
Akiba, C.
Kawamura, K.
Kamohara, C.
Sugano, H.
Tange, Y.
Karagiozov, K.
Leinonen, V.
Arai, H.
Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
title Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
title_full Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
title_fullStr Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
title_full_unstemmed Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
title_short Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
title_sort protein tyrosine phosphatase receptor type q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
topic Dementia and Cognitive Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821334/
https://www.ncbi.nlm.nih.gov/pubmed/33035386
http://dx.doi.org/10.1111/ene.14575
work_keys_str_mv AT nakajimam proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT rauramaat proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT makinenpm proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT hiltunenm proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT herukkask proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT kokkim proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT musialowiczt proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT jyrkkanenhk proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT dannern proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT junkkaria proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT koivistoam proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT jaaskelainenje proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT miyajimam proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT oginoi proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT furutaa proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT akibac proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT kawamurak proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT kamoharac proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT suganoh proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT tangey proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT karagiozovk proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT leinonenv proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus
AT araih proteintyrosinephosphatasereceptortypeqincerebrospinalfluidreflectsependymalcelldysfunctionandisapotentialbiomarkerforadultchronichydrocephalus